National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

isotretinoin
A naturally-occurring retinoic acid with potential antineoplastic activity. Isotretinoin binds to and activates nuclear retinoic acid receptors (RARs); activated RARs serve as transcription factors that promote cell differentiation and apoptosis. This agent also exhibits immunomodulatory and anti-inflammatory responses and inhibits ornithine decarboxylase, thereby decreasing polyamine synthesis and keratinization. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:13-cis-retinoic acid
13-cis-vitamin A acid
cis-retinoic acid
isotretinoinum
neovitamin A
Neovitamin A Acid
US brand names:Accutane
Amnesteem
Cistane
Claravis
Sotret
Foreign brand names:Accure
Isotrex
Isotrexin
Oratane
Roaccutan
Roaccutane
Roacutan
Abbreviation:13-CRA
Code name:Ro 4-3780
Chemical structure names:
  • 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic Acid
  • 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)2cis-4-trans-6-trans-8-trans-nonatetraenoic Acid



Previous:ISIS 2503, ISIS 3521, ISIS 5132, isoniazid, isosulfan blue
Next:Isovorin, ispinesib, ISS 1018 CpG oligodeoxynucleotide, itraconazole, Iveegam EN

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov